Skip to content

Provide Point-of-Contact

Opportunity

Clinical trial participants may have many questions and concerns during and after the clinical trial. To help address participants’ questions / concerns in a timely manner, support (e.g., phone number to call, in-app support, virtual bot) can allow clinical trial participants to receive answers and reassurance without needing to wait for the next scheduled visit. 

Considerations to Help Action the Opportunity

  • Partner with investigative sites to ensure understanding of currently available site contact support and what support sites may need to enable flexibility
  • Identify multiple options for a participant to contact / stay engaged with the investigative site or reach out to a designated contact
  • Provide a clear description of which service should be used in each situation and point of contact, if several service options are available
  • Offer service(s) in the participant’s native language and make them available 24/7
  • Partner with participants / patient organizations to ensure support services are easy to use and fit their needs​
  • Provide tools and training to enable participant self service 

Value and Potential Benefits

  • Allows participants to ask questions regarding clinical trial participation when needed, potentially alleviating concerns at the current time rather than waiting for next visit
  • May increase participant engagement by allowing stronger connectivity between participants and clinical trial staff

Tools and Resources

  • No tools or resources currently available to support this opportunity

Related Blog Posts

A Toolkit for ICH-E6(R3)

Released at the start of 2025, the ICH-E6(R3) guideline is an updated international standard for how clinical trials should be designed, conducted, recorded, and reported. At its core, the guideline ensures that people who participate in clinical trials are kept safe and that the data collected is reliable and meaningful. This guideline is not a…

Expanding clinical trial access through technology, support

Clinical trials are a key tool for producing the safety and efficacy data that guide new therapies to market. Progress in clinical research relies on those who volunteer to participate, and yet, access to trials is not the same for everyone in the United States. Read the full article featuring Allison Cuff Shimooka from TechTarget…

Good Clinical Practice has Changed: Are You Ready for ICH-E6(R3)?

ICH-E6(R3) represents a shift in mindset when it comes to clinical trials. Rather than trying to control every part of a trial equally, the guideline wants researchers to focus most on factors that are critical to participant safety and the reliability of trial results. It introduces the idea of “proportionality,” meaning more control is applied…